NCT06299098: An ongoing trial by Regeneron Pharmaceuticals
This trial is ongoing. It must report results 1 year, 11 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06299098 |
|---|---|
| Title | A Randomized, Double-Blind Study of The Efficacy and Safety of Trevogrumab, With or Without Garetosmab, in Addition to Semaglutide in Patients With Obesity |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 13, 2024 |
| Completion date | May 27, 2026 |
| Required reporting date | May 27, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 9, 2025 |
| Days late | None |